HIV Infections Clinical Trials in Miami, Florida

8 studies are recruiting for hiv infections in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

   The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) across diverse clinical settings in the United States. The study will characterize how PrEP is initiated, used, and discontinued in routine …

   Stage

   Not phased

   Ages

   18 and older

   Site

   CAN Community Health, Miami, Florida

   Locations

   38 in total

   Run by

   Gilead Sciences

   See if you can join NCT07473778 on ClinicalTrials.gov

2. A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

   This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).

   Stage

   Phase 3

   Ages

   12 and older

   Site

   GSK Investigational Site, Miami, Florida

   Locations

   88 in total

   Run by

   ViiV Healthcare

   See if you can join NCT07650916 on ClinicalTrials.gov

3. A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

   This clinical study is testing a new medication, VH4524184, to see if it can effectively treat HIV-1 in adults who have never received treatment for their infection. The study is comparing two different doses of VH4524184, each taken with the medications emtricitabine and tenofovir alafenamide (FTC…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   GSK Investigational Site, Miami, Florida

   Locations

   123 in total

   Run by

   ViiV Healthcare

   See if you can join NCT07202546 on ClinicalTrials.gov

4. The Test-to-PrEP Study

   To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Miami, Miami, Florida

   Run by

   University of Miami

   See if you can join NCT06927856 on ClinicalTrials.gov

5. Comprehensive HIV and Harm Prevention Via Telehealth

   The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.

   Stage

   Not phased

   Ages

   18 and older

   Site

   IDEA Miami, Miami, Florida

   Locations

   2 in total

   Run by

   University of Miami

   See if you can join NCT05897099 on ClinicalTrials.gov

6. Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

   The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing …

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Miami, Miami, Florida

   Run by

   University of Miami

   See if you can join NCT06730555 on ClinicalTrials.gov

7. Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

   The purpose of this study is to provide data on the pharmacokinetic (PK), safety, tolerability, efficacy and acceptability of this fixed dose combination (FDC) single tablet 2-drug regimen for virologically suppressed (HIV-1 RNA [Ribonucleic Acid] < 50 [cells per milliliter] c/mL) children 6 to les…

   Stage

   Phase 1

   Ages

   6 to 12

   Site

   GSK Investigational Site, Miami, Florida

   Locations

   8 in total

   Run by

   ViiV Healthcare

   See if you can join NCT05674656 on ClinicalTrials.gov

8. Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

   The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help pre…

   Stage

   Not phased

   Ages

   15 and older

   Site

   University of Miami, Miami, Florida

   Locations

   4 in total

   Run by

   Public Health Foundation Enterprises, Inc.

   See if you can join NCT04855773 on ClinicalTrials.gov